Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Volume: 17, Issue: 8, Pages: 1533 - 1540.e2
Published: Jul 1, 2019
Abstract
Background & AimsThere are few real-world data on the safety of vedolizumab for treatment of Crohn’s disease (CD) or ulcerative colitis (UC). We quantified rates and identified factors significantly associated with infectious and non-infectious adverse events in clinical practice.MethodsWe performed a retrospective review of data from a multicenter consortium database (from May 2014 through June 2017). Infectious and non-infectious adverse...
Paper Details
Title
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Published Date
Jul 1, 2019
Volume
17
Issue
8
Pages
1533 - 1540.e2
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History